SRAM
ATRS

Stone Ridge Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Stone Ridge Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-17,740
Closed -$39K – 1346
2018
Q1 		$39K Sell
17,740
-1,500
-8% -$3.38K ﹤0.01% 1328
2017
Q4 		$38K Buy
+19,240
New +$41.9K ﹤0.01% 1356

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stone Ridge Asset Management's ATRS Position: Q2 2018 in Review

Stone Ridge Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2018, closing a stake of 17,740 shares — an estimated $39K sold.

Stone Ridge Asset Management first reported a position in ATRS in Q4 2017 and held it in 2 quarters. The position peaked at $39K in Q1 2018. 101 funds tracked by Wall St. Rank hold ATRS as of Q2 2018.

  • Stone Ridge Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2018 after selling out during the quarter.
  • Stone Ridge Asset Management sold 17,740 Antares Pharma, Inc. shares in Q2 2018, an estimated $39K.
  • Stone Ridge Asset Management first reported a position in Antares Pharma, Inc. in Q4 2017 and held it in 2 quarters.
  • Stone Ridge Asset Management's Antares Pharma, Inc. position peaked at $39K in Q1 2018.
  • 101 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2018.

Based on Stone Ridge Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.